Co-founder, Dr. Mark Sullivan has dedicated years to researching antibodies. His collaborations with renowned biotechnology scientists have been published. Review them below to learn more.

General References

Analysis of antibody selection by phage display utilizing anti-phenobarbital antibodies

Malone J, Sullivan MA.  J Mol Recognit. 1996 Sep-Dec;9(5-6):738-45. PMID: 9174966

Recombinant human antibody single-chain variable fragments (scFv) reactive with Candida albicans surface antigens

Haidaris CG, Malone J, Sherrill LA, Bliss JM, Gaspari AA, Insel RA, Sullivan MA.  J Immunol Methods 2001; 257:185-202. PMID: 11687252

Differentiation of Candida albicans and Candida dublinensis using recombinant human antibody single chain variable fragments specific for hyphae

Bliss, JM, Sullivan MA, Malone, J. Haidaris, CG.  J Clin Microbiol, 2003 41:1152-1160. PMID: 12624045

Rapid Isolation of Antibodies for Structural Genomics

Shea C, Bloedorn L, Sullivan MA. , J Structural Funct Gen 2005; 6:171-175. PMID: 16211515  

Identification of human alpha-synuclein specific single chain antibodies

Maguire-Zeiss KA, Wang CI, Yehling E, Sullivan MA, Short DW, Su X, Gouzer G, Henricksen LA, Wuertzer CA, Federoff HJ.  Biochem Biophys Res Commun. 2006 Nov 3;349(4):1198-205. PMID: 16973126

CNS delivery of vectored prion-specific single-chain antibodies delays disease onset

Wuertzer CA, Sullivan MA, Qiu X, Federoff HJ. Mol Ther. 2008 Mar;16(3):481-6. PMID: 18180775


Inhibition of Candida albicans adhesion by recombinant human antibody single-chain variable fragment specific for Als3p

Laforce-Nesbitt SS, Sullivan MA, Hoyer LL, Bliss JM.  FEMS Immunol Med Microbiol. 2008 Nov;54(2):195-202. PMID: 18662314


A beta-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer's disease mice 

Ryan DA, Mastrangelo MA, Narrow WC, Sullivan MA, Federoff HJ, Bowers WJ. Mol. Ther 2010 18(8):1471-81. PMID: 20551911

Development and characterization of antibody reagents for detecting nanoparticles

Ravichandran S, Sullivan MA, Callahan LM, Bentley KL, DeLouise LA.  Nanoscale. 2015 Dec 21;7(47):20042-54. PMID: 26568258

Display of the HIV envelope protein at the yeast cell surface for immunogen development

Mathew E, Zhu H, Connelly SM, Sullivan MA, Brewer MG, Piepenbrink MS, Kobie JJ, Dewhurst S, Dumont ME1 . PLoS One. 2018 Oct 18;13(10):e0205756.  PMID: 30335821

Anti-idiotypic Antibodies

Anti-idiotypic Monobodies for Immune Response Profiling

Sullivan MA. Wentworth T, Kobie JJ, and Sanz I. Methods 2012. PMID: 22819856  

Sullivan MA, Brooks LR, Weidenborner P, Domm W. Mattiacio J, Xu Q, Tiberio M, Wentworth T, Kobie JJ, Byrk P, Murphy M, Sanz I, and Dewhurts S. Biochemistry 2013 52:1802-13. PMID: 23394681

Phospho Epitope and PTM Antibodies

Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 (MK2) inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity

Heo KS, Chang E, Takei Y, Le NT, Woo CH, Sullivan MA, Morrell C, Fujiwara K, and Abe J. Arterioscler Thromb Vasc Biol. 2013 Feb: 33(2): 321–329. PMID: 23202365

sNASP inhibits TLR signaling to regulate immune response in sepsis

Yang FM, Zuo Y, Zhou W, Xia C, Hahm B, Sullivan MA, Cheng J, Chang HM, and Yeh ETH. JClin Invest. 2018 Jun 1; 128(6): 2459–2472. PMID: 29733298 

A Crucial Role for p90RSK-Mediated Reduction of ERK5 Transcriptional Activity in Endothelial Dysfunction and Atherosclerosis

Le NT, Heo KS, Takei Y, Lee H, Woo CH, Change E, McClain C, Hurley C, Wang X, Li F, Xu H, Morrell C, Sullivan MA, Cohen M, Serafimova I, Taunton J, Fujiwara K, and Abe J. Circulation. 2013 Jan 29: 127 (4): 486–499. PMID: 23243209 

Heo KS, Le NT, Cushman H, Giancursio C, Chang E, Woo CH, Sullivan MA, Taunton J, Yeh ETH, Fujiwara K, and Abe J. J Clin Invest. 2015 Mar 2: 125(3): 1299–1310. PMID: 25689261


For More Information:

Find more information about Biomolecular Discovery Services and our founders here. Additionally, we'll be happy to answer any questions you may have.

Contact Us